{"product_id":"lidocaine-2-injection-mdv-50ml-25-pack","title":"Lidocaine 2% Injection, MDV 50mL 25\/Pack","description":"\u003ch2\u003eLidocaine HCl 2% Injection, 25 x 50 mL Multiple-Dose Vials — Camber Pharmaceuticals\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 31722-217-32\u003c\/p\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003ctable style=\"width: 100%; border-collapse: collapse;\" border=\"1\" cellpadding=\"8\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLidocaine hydrochloride 20 mg\/mL (2%); 1,000 mg per 50 mL vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage Form\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile injectable solution, multiple-dose vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRoute\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eInfiltration and perineural administration for local or regional anesthesia\/analgesia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackage Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e50 mL per vial; 25 vials per pack\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCamber Pharmaceuticals, Inc.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNDC\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e31722-217-32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eIndications and Usage\u003c\/h3\u003e\n\u003cp\u003eLidocaine hydrochloride injection is indicated in adults and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and obstetrical procedures, in accordance with the approved product labeling.\u003c\/p\u003e\n\u003ch3\u003eDosage and Administration\u003c\/h3\u003e\n\u003cp\u003eDosage varies depending on the procedure, the area to be anesthetized, the depth and duration of anesthesia required, and the patient's individual response. Use the lowest effective dose necessary to produce the desired effect. This 2% formulation is labeled for infiltration and nerve block and is \u003cstrong\u003enot for caudal or epidural use\u003c\/strong\u003e. Refer to the full prescribing information for specific dosing recommendations and maximum dosage limits.\u003c\/p\u003e\n\u003ch3\u003eWarnings and Precautions\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSystemic toxicity:\u003c\/strong\u003e Excessive systemic exposure may cause dose-related central nervous system and cardiovascular toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntravascular injection:\u003c\/strong\u003e Avoid inadvertent intravascular administration. Aspirate before and periodically during injection, as appropriate.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethemoglobinemia:\u003c\/strong\u003e Lidocaine may cause methemoglobinemia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUse in at-risk patients:\u003c\/strong\u003e Exercise caution in patients with hepatic impairment, cardiovascular disease, or other conditions that may increase the risk of systemic toxicity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreservative:\u003c\/strong\u003e This product contains methylparaben.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration restriction:\u003c\/strong\u003e This product is not for caudal or epidural use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eContraindications\u003c\/h3\u003e\n\u003cp\u003eContraindicated in patients with known hypersensitivity to lidocaine, other amide-type local anesthetics, or any component of the formulation.\u003c\/p\u003e\n\u003ch3\u003eAdverse Reactions\u003c\/h3\u003e\n\u003cp\u003eAdverse reactions associated with systemic lidocaine exposure may include central nervous system effects such as lightheadedness, dizziness, drowsiness, nervousness, tremor, tinnitus, confusion, and seizures. Cardiovascular effects may include hypotension, bradycardia, arrhythmias, and cardiovascular collapse. Allergic reactions and methemoglobinemia may also occur.\u003c\/p\u003e\n\u003ch3\u003eStorage and Handling\u003c\/h3\u003e\n\u003cp\u003eStore at 20°C to 25°C (68°F to 77°F) in accordance with USP Controlled Room Temperature requirements. Protect from light. Do not use if the solution is discolored or contains a precipitate.\u003c\/p\u003e\n\u003ch3\u003eHow Supplied\u003c\/h3\u003e\n\u003cp\u003eLidocaine HCl Injection, USP 2%, is supplied as a sterile, nonpyrogenic solution containing 1,000 mg\/50 mL (20 mg\/mL) in 50 mL multiple-dose vials, with 25 vials per carton.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 31722-217-32\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eProfessional use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eClinical information is summarized from FDA-approved prescribing information (Structured Product Labeling). Refer to the full prescribing information via DailyMed for complete details.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eIf you have questions related to DSCSA compliance, transaction history, regulatory data, or quality assurance, please contact our team at \u003ca href=\"mailto:compliance@dryeyerescue.com\"\u003ecompliance@dryeyerescue.com\u003c\/a\u003e.\u003c\/p\u003e","brand":"Camber Pharmaceuticals","offers":[{"title":"Default Title","offer_id":67669680292205,"sku":"RX-2035","price":124.99,"currency_code":"USD","in_stock":false}],"url":"https:\/\/wholesale.dryeyerescue.com\/products\/lidocaine-2-injection-mdv-50ml-25-pack","provider":"Dryeye Rescue Pro","version":"1.0","type":"link"}